Prof Ashley Bush
Abdel Ali Belaidi
Adam Gunn
Adam Southon
Alejandra Elvira Ramirez Munoz
Ambili Thoppuvalappil Appukuttan
Amelia Sedjahtera
Amit Lotan
Anna Schroeder
Antonia Lynch
Ashley Bush
Ashley Portbury
Ashwinie Ukuwela
Brian Stevens
Carlos Opazo Martinez
Celeste Mawal
David Finkelstein
Erin McAllum
Feng Chen
Fernanda Yevenes Ugarte
Fransisca Sumardy
Gawain Mccoll
Hudson Trytell
Ibrahima Diouf
Irene Volitakis
James Duce
Jennifer Chambers
Jessica Billings
Karla Acevedo
Kim McAuliffe
Kirsten Grant
Krista Dent
Linh Lam
Lisa Bray
Lydia Nugroho
Mahtab Ameri-Sefideh
Mark Greenough
Mun-Joo Chuei
Nakisa Malakooti
Nicole Jenkins
Noel Faux
Olga Shimoni
Patricia Chege Mugure
Paul Adlard
Peng Lei
Pravat Mandal
Reza Tondfekr
Robert Cherny
Sandra Luza
Scott Ayton
Shashank Masaldan
Simon James
Steve Moon
Stuart Portbury
Tessa Consedine
Tetsufumi Kanazawa
Ya Hui Hung
Zhiguang Xiao
Zhiwen Zeng
Oxidation Biology Unit
This group has a particular interest in uncovering the pathways that lead to a variety of neurodegenerative diseases, especially those pathways in which metal ions (such as zinc, copper and iron) interact with key target proteins. Studies of these pathways have led to new insights for drug therapies for Alzheimer’s disease and Huntington disease.
Atomic Pathology Laboratory
Dr Dominic Hare
Biophysics Laboratory
Dr Simon Drew
Molecular Gerontology Laboratory
Dr Gawain Mccoll
Motor Neurone Disease Laboratory
Dr Bradley Turner
National Dementia Diagnostics Laboratory
Prof Steven Collins
Prof Colin Masters
Neurochemistry of Metal Ions
Dr Zhiguang Xiao
Neurotherapeutics Laboratory
A/Prof Kevin Barnham
Oxidation Biology Unit
Prof Ashley Bush
Parkinson's Disease Laboratory
Mr Malcolm Horne
Prana Laboratory
Dr Robert Cherny
Presynaptic Physiology
Dr Sarah Gordon
Steroid Neurobiology Laboratory
Dr Wah Chin Boon
Synaptic Neurobiology Laboratory
A/Prof Paul Adlard
Neurodegeneration
Scientists in the Neurodegeneration division interrogate how neurones live, die and can be rescued to improve brain function in degenerative conditions such as Parkinson’s and Motor Neuron Diseases. There is no effective treatment for Motor Neurone Disease and the incidence of Parkinson’s Disease is rising alarmingly in our aging community. Gene abnormalities, energy deprivation, toxic rubbish accumulation and inflammation all contribute to a toxic environment for brain cells. Our teams study these events in animal models and cultured cells, with a view to translating knowledge into new therapies for human patients.